Ensign Group Performance Comparison

Loading chart data...

Stock Range

Today's Range

Low: $169.25 High: $173.62
on August 22, 2025

52 Week Range

Low: $118.73 High: $173.62
on April 21, 2025
on August 22, 2025

All-Time High: $173.71 on August 22, 2025

Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights

Key Statistics

Market Cap i $9.8B
EPS i 5.52
P/E Ratio (TTM) i 30.66
Forward P/E i 27.56
P/B Ratio i 4.80
PEG Ratio i 1.76
Div. Yield i 0.20%
ROE i 17.54%
Beta i 1.018
Debt to Equity i 100.93

Financial Highlights

Profitability

Gross Margin i 16.19%
Operating Margin i 8.46%
Profit Margin i 7.00%

Returns and Earnings

Return on Assets (TTM) i 5.30%
Return on Equity (TTM) i 17.54%
EBITDA i $525.7M
Net Income (TTM) i $322.8M

Growth

Revenue (TTM) i
Revenue Per Share (TTM) i $80.34
Quarterly Revenue Growth (YoY) i 18.50%
Quarterly Earnings Growth (YoY) i 18.90%

Dividend Information

Last 12-Month Dividend i $0.30
Current Dividend Yield i 0.20%
3-Year Average Dividend Yield i 0.05%
3-Year Average Annual Dividend i $0.26
3-Year Total Dividends i $0.78
Ex-Dividend Date i June 30, 2025

Peer Performance Comparison

Performance comparison table showing returns for peer companies over various time periods
CompanyMarket Cap1W1M3M6MYTD1Y3Y5Y
Ensign Group ENSG 9.77B Mid-cap3.77%26.46%19.21%33.58%29.78%16.46%98.37%194.07%
HCA Healthcare HCA 94.59B Large-cap2.32%15.39%7.52%26.72%36.01%4.16%97.57%197.79%
Tenet Healthcare THC 15.67B Large-cap4.35%15.09%11.26%36.44%43.35%9.10%198.82%523.05%
DaVita DVA 9.84B Mid-cap3.68%-3.90%1.33%-1.18%-6.31%-8.85%58.33%61.44%
Chemed CHE 6.62B Mid-cap3.13%1.36%-18.24%-16.11%-13.05%-19.80%-3.27%-10.18%
Option Care Health OPCH 4.66B Mid-cap1.48%-3.49%-10.27%-10.41%26.61%-9.71%-9.02%143.77%

Ownership & Short Interest

Insider Ownership i 3.43%
Institutional Ownership i 95.02%
Shares Short i 2M
Short Ratio i 3.98
Short % of Shares Outstanding i 4.12%
Average 10-Day Volume i 366K
Average 90-Day Volume i 451K

Ensign Group Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Ensign Group would have performed over time.

$
If not specified, the latest available data will be used

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

In the last 52 weeks, Ensign Group reached a high of $173.62 (on August 22, 2025) and a low of $118.73 (on April 21, 2025).
Curious about Ensign Group's size and valuation? Its market capitalization stands at 9.77B. When it comes to valuation, the P/E ratio (trailing twelve months) is 30.66, and the forward P/E (looking ahead) is 27.56.
Yes, Ensign Group is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.20%, and the company has paid an average of $0.26 per share annually over the past 3 years.

When looking at Ensign Group, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

CompanyMkt CapSectorIndustry1Y Return3Y Return
HCA Healthcare
HCA
94.59BHealthcareMedical Care Facilities4.16%97.57%
Tenet Healthcare
THC
15.67BHealthcareMedical Care Facilities9.10%198.82%
DaVita
DVA
9.84BHealthcareMedical Care Facilities-8.85%58.33%
Chemed
CHE
6.62BHealthcareMedical Care Facilities-19.80%-3.27%
Option Care Health
OPCH
4.66BHealthcareMedical Care Facilities-9.71%-9.02%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

To get a sense of Ensign Group's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 17.54%, the Debt to Equity ratio from the most recent quarter is 100.93, and its Gross Profit Margin stands at 16.19%.
Looking at Ensign Group's growth, its revenue over the trailing twelve months (TTM) was $5B. Compared to the same quarter last year (YoY), quarterly revenue grew by 18.50%, and quarterly earnings saw a YoY growth of 18.90%.
Wondering who owns Ensign Group stock? Company insiders (like executives and directors) hold about 3.43% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 95.02%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.